ASCO 2026 Highlights Infographic
The Infographic Offers Key Insights Into:
- Discover where innovation is accelerating, as bispecifics emerge as one of ASCO 2026s fastest-growing modalities
- Explore how RAS-targeted therapies are expanding beyond KRAS G12C into new precision oncology opportunities
- Identify the tumor types generating the greatest clinical and commercial attention at ASCO 2026
- Review the late stage readouts attracting attention across disease indications including pancreatic cancer, sarcoma, lung cancer and breast cancer
You May Also Be Interested In…
Learn More About Oncology
What is Beacon Oncology?
- The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
- Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
